Not Tagged
Not Tagged
['mds']
we now have 2 randomized phase 3 in lower risk #mdssm patients where 8-week rbc transfusion independence was 13-15% in placebo arm! it emphasizes importance of double blinding &amp; a control arm. rbc ti in open-label or single arm studies should be taken with caution #asco23 
Associate Prof, Ast Director CTO, Director Heme early phase/#Leuksm research @Yale. @LLSusa Scholar in Clinical Research. Own Opinion. COI https://t.co/6XkF8CmtrK